Literature DB >> 17502397

PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004.

Ivano de Filippis1, Claudia Ferreira de Andrade, Luciete Silva, D Rebecca Prevots, Ana Carolina P Vicente.   

Abstract

The high genetic diversity found among the PorA regions VR1 and VR2 of 101 Neisseria meningitidis isolates from patients with meningococcal disease and healthy carriers in Brazil contrasts with the stability found in the PorA VR3 of these isolates. The presence of VR3 epitope variant 35 or 36 on the surfaces of 87% of the strains analyzed suggests that these antigens should be considered for inclusion in new formulations of vaccines against serogroup B meningococci in Brazil.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502397      PMCID: PMC1932963          DOI: 10.1128/IAI.01721-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Long-term persistence of a discotheque-associated invasive Neisseria meningitidis group C strain as proven by pulsed-field gel electrophoresis and porA gene sequencing.

Authors:  K Riesbeck; P Orvelid-Mölling; H Fredlund; P Olcén
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Detection and genotyping of meningococci using a nested PCR approach.

Authors:  M A Diggle; S C Clarke
Journal:  J Med Microbiol       Date:  2003-01       Impact factor: 2.472

3.  Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?

Authors:  S C Clarke; M A Diggle; P Mölling; M Unemo; P Olcén
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

4.  Immunogenicity of peptide-vaccine candidates predicted by molecular dynamics simulations.

Authors:  Clasien J Oomen; Peter Hoogerhout; Alexandre M J J Bonvin; Betsy Kuipers; Humphrey Brugghe; Hans Timmermans; Simon R Haseley; Loek van Alphen; Piet Gros
Journal:  J Mol Biol       Date:  2003-05-16       Impact factor: 5.469

5.  Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

Authors:  Rachel Urwin; Joanne E Russell; Emily A L Thompson; Edward C Holmes; Ian M Feavers; Martin C J Maiden
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Topology of outer membrane porins in pathogenic Neisseria spp.

Authors:  P van der Ley; J E Heckels; M Virji; P Hoogerhout; J T Poolman
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

7.  Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis.

Authors:  S C Clarke; M A Diggle; G F Edwards
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.

Authors:  Jamie Findlow; Stephen Taylor; Audun Aase; Rachel Horton; Robert Heyderman; Jo Southern; Nick Andrews; Rita Barchha; Ewan Harrison; Ann Lowe; Emma Boxer; Charlotte Heaton; Paul Balmer; Ed Kaczmarski; Philipp Oster; Andrew Gorringe; Ray Borrow; Elizabeth Miller
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

9.  Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases.

Authors:  P Mölling; M Unemo; A Bäckman; P Olcén
Journal:  APMIS       Date:  2000 Jul-Aug       Impact factor: 3.205

10.  PorA variable regions of Neisseria meningitidis.

Authors:  Joanne E Russell; Keith A Jolley; Ian M Feavers; Martin C J Maiden; Janet Suker
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

View more
  2 in total

1.  Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688.

Authors:  Chivonne Moodley; Mignon du Plessis; Kedibone Ndlangisa; Linda de Gouveia; Keith P Klugman; Anne von Gottberg
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

2.  Short-term and long-term antibody response by mice after immunization against Neisseria meningitidis B or diphtheria toxoid.

Authors:  G P Silva; S C Cruz; A C Cruz; L G Milagres
Journal:  Braz J Med Biol Res       Date:  2013-02-01       Impact factor: 2.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.